Unicycive Therapeutics Inc (NASDAQ:UNCY) traded at $6.68 at close of the session on Friday, June 20 and made an upward move of 6.34% on its previous day’s price.
Looking at the stock we see that its previous close was $57.14 and the beta (5Y monthly) reads 2.001 with the day’s price range being $4.84 – $6.37. In terms of its 52-week price range, UNCY has a high of $42.36% and a low of $11.00. The company’s stock has gained about 5.67% over that past 30 days.
Unicycive Therapeutics Inc has a market cap of $80.14 million and is expected to release its quarterly earnings report on 2025-May-14.
Based on estimates by 2 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Unicycive Therapeutics Inc (UNCY) stock as a Hold, while 2 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 22 off its SMA20 and 0.00 from its 50-day simple moving average.
Coming back to Unicycive Therapeutics Inc (NASDAQ:UNCY), we note that the average 3-month trading volume was 8.08, while that of the preceding 10-day period stands at 1.39 million. Current shares outstanding are 12.64 million.
The insiders hold 5.20% of the company’s shares while institutions hold 16.50%. The data shows that short shares as of 2025-05-30, stood at 35689.0 at a short ratio of 0.41. This represents a 3.00 short interest in shares outstanding on 2025-05-30. Shares short fall in May from the previous month at 79304.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -2.51% down in year-to-date price movement.
